Salt mystery in POTS: do kidneys hold the key?
NCT ID NCT00581633
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares how the kidneys handle salt in people with postural orthostatic tachycardia syndrome (POTS) versus healthy volunteers. Researchers give a liter of saline intravenously and measure how much sodium is excreted in urine. The goal is to see if POTS patients have trouble conserving salt, which could help explain their symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- normal saline (0.9%)
- What this could lead to
- If successful, this could help explain why some people with POTS have trouble regulating salt and water, potentially pointing toward better management strategies.
- What could go wrong
- This is a small, early-stage observational study with only 30 participants. It is not testing a treatment, so it may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Feb 2007
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with orthostatic intolerance by Vanderbilt Autonomic Dysfunction Center (or healthy control subject) Exclusion Criteria: * Overt or acute cause for orthostatic tachycardia * Hypertension (BP\>145/95 or need for anti-hypertensive medications) * QRS duration \> 120 msec on EKG * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Orthostatic intolerance are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two common drugs tame the debilitating symptoms of POTS?
- Could ear nerve stimulation calm racing hearts in POTS?
- Can CO2 calm POTS? small study investigates
- Could antibodies be behind POTS? new study investigates
- Could muscle loss in seniors cause tiredness and dizziness? new study investigates
- Could a simple handgrip prevent fainting? new study investigates